tiprankstipranks
Trending News
More News >
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Financial Statements

Compare
5 Followers

GlaxoSmithKline Pharmaceuticals Limited Financial Overview

GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹402.25B. The company's EPS TTM is ₹15; its P/E ratio is 42.11; and it has a dividend yield of 2.16%. GlaxoSmithKline Pharmaceuticals Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 37.49B₹ 34.54B₹ 32.52B₹ 32.78B₹ 29.26B
Gross Profit₹ 23.35B₹ 20.99B₹ 19.48B₹ 19.00B₹ 16.43B
Operating Income₹ 16.31B₹ 13.60B₹ 12.39B₹ 11.58B₹ 9.56B
EBITDA₹ 11.53B₹ 8.81B₹ 7.88B₹ 7.43B₹ 5.73B
Net Income₹ 9.28B₹ 5.90B₹ 6.11B₹ 16.95B₹ 3.58B
Balance Sheet
Cash & Short-Term Investments₹ 24.98B₹ 18.57B₹ 16.54B₹ 29.03B₹ 11.63B
Total Assets₹ 41.08B₹ 35.57B₹ 33.27B₹ 46.33B₹ 31.13B
Total Debt₹ 99.50M₹ 186.65M₹ 155.40M₹ 200.76M₹ 346.27M
Net Debt₹ -13.94B₹ -455.06M₹ -194.00M₹ -2.66B₹ -3.71B
Total Liabilities₹ 21.57B₹ 17.79B₹ 15.85B₹ 19.70B₹ 16.14B
Stockholders' Equity₹ 19.51B₹ 17.78B₹ 17.41B₹ 26.63B₹ 14.78B
Cash Flow
Free Cash Flow₹ 12.67B₹ 5.51B₹ 4.40B₹ 7.76B₹ 5.34B
Operating Cash Flow₹ 12.90B₹ 5.82B₹ 4.84B₹ 8.11B₹ 5.78B
Investing Cash Flow₹ -458.10M₹ 87.12M₹ 8.08B₹ -4.06B₹ 4.19B
Financing Cash Flow₹ -7.69B₹ -5.61B₹ -15.43B₹ -5.24B₹ -6.96B
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

GlaxoSmithKline Pharmaceuticals Limited Debt to Assets

GlaxoSmithKline Pharmaceuticals Limited Cash Flow

GlaxoSmithKline Pharmaceuticals Limited Forecast EPS vs Actual EPS